This Week In Cannabis: Trump's Reform Buzz Drives Stocks Up, RAW's Secret Factory, Global Shifts And More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 25 2025
0mins
Source: Benzinga
Market Trends: Cannabis stocks have seen a rally due to federal reform discussions, particularly involving Donald Trump, but analysts advise caution as the market remains volatile. Meanwhile, global cannabis developments include Portugal becoming Europe's largest exporter and Spain banning certain cannabinoids.
Industry Developments: Notable changes in the cannabis sector include Body and Mind selling a dispensary to focus on retail expansion, Cresco Labs opening a new cultivation facility in Kentucky, and California cities reducing cannabis taxes to support struggling local stores.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 87.79 USD with a low forecast of 77.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 85.240
Low
77.00
Averages
87.79
High
95.00
Current: 85.240
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Colgate-Palmolive's 2026 Outlook Shows Optimism Amid Challenges
- 2026 Sales Growth Guidance: Colgate-Palmolive provided a 1% to 4% organic sales growth guidance for 2026, reflecting market volatility and potential category growth, indicating a cautiously optimistic outlook despite uncertainties.
- Financial Performance Highlights: The company achieved a record operating cash flow of $4.2 billion in Q4, demonstrating resilience and profitability despite challenges from raw material inflation and tariffs, with organic sales growth across all four categories.
- Strategic Transformation Plan: Colgate announced a new 2030 strategy focusing on digitalization, data analytics, and supply chain optimization, aiming to leverage innovation and a flexible operating model to navigate market challenges and drive long-term growth.
- Market Share and Advertising Spend: Despite weak performance in North America, Colgate increased advertising spend by 5% year-over-year, reflecting ongoing efforts to enhance brand visibility and market share, even as the overall environment remains challenging.
Continue Reading
US Stocks Close Lower Amid Cautious Market Sentiment
- Stock Index Declines: The S&P 500 index fell by 0.43%, the Dow Jones Industrial Average dropped by 0.36%, and the Nasdaq 100 decreased by 1.28%, reflecting cautious investor sentiment following President Trump's nomination of Kevin Warsh as the new Fed Chair, which raised concerns about future monetary policy.
- Producer Prices Rise: The US December Producer Price Index (PPI) increased by 0.5% month-over-month and 3.0% year-over-year, both exceeding market expectations, indicating heightened inflationary pressures that could influence the Fed's policy decisions moving forward.
- Mining Stocks Plummet: Mining stocks faced significant sell-offs as gold and silver prices dropped sharply, with Coeur Mining and Hecla Mining declining over 17% and 15%, respectively, reflecting a pessimistic outlook on precious metals amid rising dollar strength.
- Positive Earnings Outlook: Despite the overall market decline, 102 S&P 500 companies are set to report earnings this week, with 77% of the 143 companies that have reported so far exceeding expectations, indicating resilience in corporate profitability, with S&P earnings growth projected to reach 8.4% in Q4.
Continue Reading